1. Home
  2. WD vs AVDL Comparison

WD vs AVDL Comparison

Compare WD & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Walker & Dunlop Inc

WD

Walker & Dunlop Inc

HOLD

Current Price

$63.63

Market Cap

2.1B

Sector

Finance

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.49

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WD
AVDL
Founded
1937
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
WD
AVDL
Price
$63.63
$21.49
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$83.33
$18.38
AVG Volume (30 Days)
257.9K
1.6M
Earning Date
02-12-2026
03-02-2026
Dividend Yield
4.10%
N/A
EPS Growth
20.18
N/A
EPS
3.37
N/A
Revenue
$1,160,070,000.00
$248,517,000.00
Revenue This Year
$21.20
$65.47
Revenue Next Year
$10.20
$30.88
P/E Ratio
$19.41
N/A
Revenue Growth
17.65
79.88
52 Week Low
$58.60
$6.38
52 Week High
$97.70
$23.57

Technical Indicators

Market Signals
Indicator
WD
AVDL
Relative Strength Index (RSI) 51.39 57.12
Support Level $62.56 $21.45
Resistance Level $66.47 $21.60
Average True Range (ATR) 1.68 0.07
MACD 0.67 -0.04
Stochastic Oscillator 63.91 51.22

Price Performance

Historical Comparison
WD
AVDL

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: